Further research found that IL-35 upregulated IL-10 expression and reduced monocyte infiltration in the spinal cord, indicating that IL-35 can attenuate MS-associated pain in females by decreasing neuroinflammation and increasing myelination. The gene discussed is IL10; the disease is myeloid sarcoma.